The epiCard ®
Designed by patients at risk for anaphylaxis, Intelliject's epiCard ® is designed to be small, safe and user-friendly. As a result of Intelliject's human factors engineering design expertise and strong intellectual property platform, epiCard ® is a patient-centric prescription product that is intended to allow the at-risk patient to manage his/her severe allergic emergency with confidence, and without fear.
* The epiCard ® is in late stages of development.
1. epiCard ®: The Problem Statement
2. The epiCard ®: Device
3. The PromptSystem™
What We Do
This website is intended solely for entities that are potential commercial partners of Intelliject, Inc. Members of the public, patients and healthcare professionals should not enter this website.
Intelliject currently has no approved products and nothing herein should be considered a promotional claim.
All information contained herein is intended to assist interested parties in assessing possible commercial relationships with Intelliject, Inc. All information is believed to be correct at the date of posting but may change at any time.
